Mostrando 2 resultados de: 2
Clinical pbkp_redictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort
ArticleAbstract: Objectives: To identify baseline pbkp_redictors of remission and low disease activity (LDA) in earlyPalabras claves:Early RA outcomes, Early RA remission, Early RA response pbkp_redictors, Latin America early RAAutores:Achurra-Castillo A.F., Alarcón G.S., Andrade-Ortega L., Appenzeller S., Ballesteros F., Barile-Fabris L.A., Bianchi W.A., Caballero-Uribe C.V., Cardiel M.H., Castelar-Pinheiro G.d.R., Claudio M. Galarza-Maldonado, Da Silveira I.G., de Freitas Zerbini C.A., Esquivel-Valerio J.A., Esteva-Spinetti M.H., Gamboa-Cárdenas R.V., García de la Torre I., Guibert-Toledano M., Loreto M., Monge P., Montufar R.A., Palezuelos F.I., Pisoni C.N., Pons-Estel B.A., Radominski S.C., Rios C., Rojas-Villarraga A., Sacnun M.P., Saurit V., Soriano E.R., Teijeiro R., Ugarte-Gil M.F., Vazquez-Mellado J.Fuentes:scopusUse of rituximab for the treatment of rheumatoid arthritis: The Latin American context
ArticleAbstract:Palabras claves:Anti-CD20 antibody, Biologic therapy, Latin America, Rheumatoid Arthritis, rituximab, Treatment guidelinesAutores:Achurra-Castillo A.F., Alarcón G.S., Barile-Fabris L.A., Caballero-Uribe C.V., Cardiel M.H., Chávez-Corrales J.E., Claudio M. Galarza-Maldonado, Díaz-Coto J.F., Esteva-Spinetti M.H., Guibert-Toledano M., Keiserman M.W., Lomonte A.V., Massardo L., Mota L.M.H., Palazuelos I.F., Pineda-Villaseñor C., Pons-Estel B.A., Soriano E.R.Fuentes:scopus